Influencing factors of pathological complete response in triple-negative breast cancer with neoadjuvant chemotherapy
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 3
Abstract
Objective To analyze the clinical and pathological factors affecting pathological complete response (pCR) of triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NAC). Methods A retrospective analysis was conducted in 78 TNBC patients treated with NAC and surgery in The First Affiliated Hospital of Xinjiang Medical University from January 2018 to September 2023. The patients were divided into pCR group (n=28) and non-pCR group (n=50) based on whether they had achieved pCR or not. Logistic regression analysis was used to investigate the clinical and pathological factors affecting pCR. The pCR rate and incidence of adverse reactions after NAC between TP regimen (taxane+platinum) and TAC regimen (taxane+anthracycline+cyclophosphamide) were compared. Results The overall pCR rate was 35.9%. There were statistically significant differences between the two groups of patients in tumor diameter, chemotherapy cycle, chemotherapy regimen, paclitaxel type, human epidermal growth factor receptor 2 (HER-2) expression, Ki-67 expression, and androgen receptor (AR) positive expression (P＞0.05). Multivariate logistic regression analysis showed that tumor diameter ≤ 3 cm was an independent favorable factor of pCR(OR=4.191, 95%CI: 1.246-14.094, P=0.021), and AR positive expression was an independent unfavorable factor of pCR (OR=0.124, 95%CI: 0.020-0.784, P=0.027). In addition, the pCR rate of the TP regimen was significantly better than that of the TAC regimen ［54.8%(17/31) vs 28.1%(9/32), χ2=4.636, P=0.031］, and there was no significant difference in the incidence of adverse reactions between two groups (P＞0.05). Conclusion TP or TAC regimen and albumin bound paclitaxel in NAC for TNBC is beneficial for achieving pCR status, but the pCR rate of TP regimen is better than that of TAC regimen, and the incidence of adverse reactions is comparable. The pCR rate is higher for tumor diameter≤3 cm, while low expression of HER-2, Ki-67, or AR indicates a lower pCR rate. AR positive expression is an independent unfavorable factor of pCR.
Authors and Affiliations
DUAN Shuai, Dilimulati Aisimutula, WANG Haiyan, GUO Chenming
Keywords
Related Articles
- EP ID EP734501
- DOI 10.13429/j.cnki.cjcr.2024.03.006
- Views 67
- Downloads 0
Effect of subanesthetic dose of esketamine on perioperative hemodynamics in patients undergoing lumbar surgery under general anesthesia
Objective To analyze the effect of subanesthetic dose of esketamine on perioperative hemodynamics and adverse events in patients undergoing lumbar spine surgery under general anesthesia. Methods The clinical data of 70...
Microsurgical treatment of severe aneurysmal subarachnoid hemorrhage: an analysis of 14 cases
"<b>Objective</b> To analyze the therapeutic effect of microsurgery on patients with severe aneurysmal subarachnoid hemorrhage (SaSAH). <b>Methods</b> A retrospective analysis was conducted on 14 SaSAH patients admit...
Comparison of short-term efficacy between unilateral biportal endoscopic lumbar interbody fusion and minimally invasive surgery transforaminal lumbar interbody fusion for lumbar spinal stenosis
<b>Objective</b> To compare the short-term efficacy of unilateral biportal endoscopic lumbar interbody fusion (ULIF) and minimally invasive surgery transforaminal lumbar interbody fusion (MIS-TLIF) in the treatment of l...
Application of artificial intelligence system based on control theory feedback model in ultrasound diagnosis and treatment medical insurance payment
Objective To analyzes the optimization function of artificial intelligence system based on control theory feedback model applied to medical insurance payment. Methods Aiming at the unclear category of ultrasonic diagnosi...
Expression and clinical significance of tumor necrosis factor receptor superfamily 4 in laryngeal squamous cell carcinoma
<b>Objective</b> To analyze the changes in tumor necrosis factor receptor superfamily (TNFRSF) 4 expression levels in laryngeal squamous cell carcinoma (LSCC) patients through multiple database data combined with clinic...